2013 Annual Meeting | Chronic Migraine ��ɫ�� Program

Date Friday 03/22/13

Time 01:00 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Half-Day Course

Director(s) Richard B. Lipton, MD, FAAN

Topic(s)

Learning Objectives Participants should be better able to: correctly apply criteria for the clinical diagnosis and differential diagnosis of chronic migraine and episodic migraine using diagnostic algorithms; identify strategies for the optimal acute treatment of migraine; understand the scope, burden, and distribution of chronic migraine in the population as well as the risk factors that predispose to it; distinguish current patterns in the diagnosis and treatment of chronic migraine and episodic migraine, and the substantial unmet medical need for this condition; describe emerging insights into the pathophysiology of chronic migraine; identify common comorbidities in patients with chronic migraine; and implement evidence-based strategies for chronic migraine management.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
01:00 PM - 01:10 PM		Introduction: Opening Comments and Pre-test Richard B. Lipton, MD, FAAN
01:10 PM - 01:40 PM		Diagnosing Chronic Migraine and Episodic Migraine Stephen D. Silberstein, MD, FAAN
01:40 PM - 02:10 PM		Transitions, Risk Factors, and Barriers to Care Richard B. Lipton, MD, FAAN
02:10 PM - 02:30 PM		Case Studies and Q & A Stephen D. Silberstein, MD, FAAN
02:30 PM - 03:00 PM		Pathophysiology of Chronic Migraine and Episodic Migraine Sheena K. Aurora, MD
03:00 PM - 03:15 PM		Break
03:15 PM - 03:45 PM		Outpatient Treatment Options for Chronic Migraine Lawrence C. Newman, MD, FAAN
03:45 PM - 04:15 PM		Inpatient and Invasive Treatment Options For Chronic Migraine Stephen D. Silberstein, MD, FAAN
04:15 PM - 04:45 PM		Questions and Answers and Another Case Richard B. Lipton, MD, FAAN
04:45 PM - 05:00 PM		Concluding Remarks and Post-test Richard B. Lipton, MD, FAAN

Faculty Disclosures
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Stephen D. Silberstein, MD, FAAN	Dr. Silberstein has received publishing royalties from a publication relating to health care.
Lawrence C. Newman, MD, FAAN	Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan . Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Newman has received publishing royalties from a publication relating to health care.
Sheena K. Aurora, MD	Dr. Aurora has received personal compensation for serving as an employee of C2N Diagnostics. Dr. Aurora has stock in Impel Neurpharma.

��ɫ����

��ɫ����

��ɫ��

��ɫ��